Economics and health are connected in many ways. John Mauldin in his May 16, 2015 letter paraphrases economist Bill White:
Central bank models, he told us, are artificial machines. His best quote was, “The basic problem with central banks: they think they know how the economy works.” Their models are built to be gamed and always assume a return to equilibrium. But there is no equilibrium – you are where you are. The problem with equilibrium models is that they don’t reflect reality.
An economy is like a forest ecosystem, not a machine. We are on a very bad path – debt is unsustainable. Notice the environment since the 2008 crisis: the Eurozone crisis is a limited variant on a global crisis; fiscal and regulatory restraint is not helpful; and monetary policy is the only game in town and is not effective.
Rheumatic diseases are not new. Ramses II suffered with ankylosing spondylitis (Greek “crooked vertebrae”).
Nowadays, we have new risk factors for inflammation, which spells more rheumatic arthritis (RA) such as psoriasis, lupus and ankylosing spondylitis.
Even as 10,000 years ago, RA risk starts with genetics. Some of us have an allele called HLA-B27 which is associated with arthritis. If you have HLA-B27, you have greater risk of autoimmune arthritis.
A diabetes study found that being overweight is linked to better survival, and being thin is the biggest risk (Costanzo et al 2015).
Here’s a piece by Mike Adams from 2006 that holds water in explaining absolute risk versus relative risk: Continue reading
To understand today’s healthcare, we will measure what metrics make its foundation. This involves looking at improvement percentages, including tradeoffs, of highly successful drugs in the marketplace.
The following will display data about percentages of “betterment”, such that substance which achieve competitive percentages should be considered by a fair government as medicine.